Metoprolol Lph

Metoprolol tartrate, the active ingredient in Metoprolol Lph, is a beta blocker presented as an oral tablet for systemic use. It lowers elevated blood pressure, relieves angina, and improves outcomes after myocardial infarction and in chronic heart failure, primarily in adult patients.

GNH USA supplies Metoprolol Lph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing batch‑tested product for global distribution.

Metoprolol tartrate is used to manage cardiovascular conditions that involve excessive sympathetic activity.

Hypertension: reduces systolic and diastolic blood pressure. Angina pectoris: decreases myocardial oxygen demand and relieves chest pain. Post‑myocardial infarction: lowers risk of recurrent ischemic events and improves survival. Heart failure: improves left‑ventricular function and reduces hospitalisation. Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other tachyarrhythmias.

Metoprolol tartrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort) - Headache

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma or COPD - Allergic reactions such as rash, angioedema, or anaphylaxis - Depression or mood changes - Worsening heart failure symptoms

When prescribing metoprolol tartrate, clinicians should observe several precautionary measures to ensure safe use.

Monitor blood pressure: check regularly to avoid excessive hypotension. Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. Review cardiac function: consider baseline ejection fraction and recent myocardial events. Adjust in renal/hepatic impairment: dose may need reduction in patients with organ dysfunction. Caution in asthma or COPD: β1‑selectivity may not fully prevent bronchospasm. Store at ambient temperature: keep in the original container, protect from moisture.

Metoprolol tartrate can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Concomitant use with non‑dihydropyridine calcium‑channel blockers (verapamil, diltiazem) may cause profound bradycardia or AV block. - Co‑administration with clonidine followed by abrupt discontinuation can precipitate severe hypertension. - Combined with insulin or oral hypoglycemics may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely): - NSAIDs may reduce the antihypertensive effect of metoprolol. - Diuretics can potentiate hypotensive responses. - Other beta‑blockers increase the risk of excessive bradycardia. - Certain antidepressants (e.g., SSRIs) may affect plasma concentrations of metoprolol.